Molina Healthcare, Inc. (MOH)
USD 318.04
(1.6%)
USD 318.04
(1.6%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.38 Billion USD | -0.25% |
| 2022 | 2.39 Billion USD | -0.04% |
| 2021 | 2.39 Billion USD | 1.7% |
| 2020 | 2.35 Billion USD | 58.28% |
| 2019 | 1.48 Billion USD | 1.92% |
| 2018 | 1.45 Billion USD | -32.78% |
| 2017 | 2.16 Billion USD | 31.85% |
| 2016 | 1.64 Billion USD | 2.24% |
| 2015 | 1.6 Billion USD | 77.71% |
| 2014 | 905.38 Million USD | 15.36% |
| 2013 | 784.86 Million USD | 198.5% |
| 2012 | 262.93 Million USD | 8.87% |
| 2011 | 241.52 Million USD | 28.02% |
| 2010 | 188.66 Million USD | 2.34% |
| 2009 | 184.35 Million USD | -7.82% |
| 2008 | 200 Million USD | 0.0% |
| 2007 | 200 Million USD | 344.44% |
| 2006 | 45 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 1.89 Million USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 3.35 Million USD | -1.5% |
| 2001 | 3.4 Million USD | 0.0% |
| 2000 | - USD | -100.0% |
| 1999 | 17.29 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.38 Billion USD | -0.13% |
| 2024 Q2 | 2.38 Billion USD | 0.08% |
| 2024 Q3 | 2.33 Billion USD | 6.08% |
| 2023 Q3 | 2.37 Billion USD | -0.13% |
| 2023 Q1 | 2.38 Billion USD | -0.42% |
| 2023 FY | 2.38 Billion USD | -0.25% |
| 2023 Q2 | 2.38 Billion USD | 0.0% |
| 2023 Q4 | 2.38 Billion USD | 0.29% |
| 2022 Q3 | 2.39 Billion USD | 0.04% |
| 2022 FY | 2.39 Billion USD | -0.04% |
| 2022 Q1 | 2.39 Billion USD | -0.04% |
| 2022 Q2 | 2.39 Billion USD | 0.0% |
| 2022 Q4 | 2.39 Billion USD | -0.04% |
| 2021 Q1 | 2.35 Billion USD | -0.04% |
| 2021 FY | 2.39 Billion USD | 1.7% |
| 2021 Q4 | 2.39 Billion USD | 1.79% |
| 2021 Q3 | 2.35 Billion USD | -0.09% |
| 2021 Q2 | 2.35 Billion USD | 0.04% |
| 2020 Q3 | 2.03 Billion USD | -0.1% |
| 2020 Q1 | 1.85 Billion USD | 24.56% |
| 2020 FY | 2.35 Billion USD | 58.28% |
| 2020 Q4 | 2.35 Billion USD | 15.35% |
| 2020 Q2 | 2.04 Billion USD | 10.26% |
| 2019 FY | 1.48 Billion USD | 1.92% |
| 2019 Q4 | 1.48 Billion USD | -0.07% |
| 2019 Q1 | 1.55 Billion USD | 6.52% |
| 2019 Q3 | 1.48 Billion USD | -3.32% |
| 2019 Q2 | 1.53 Billion USD | -0.97% |
| 2018 Q3 | 1.51 Billion USD | -11.05% |
| 2018 FY | 1.45 Billion USD | -32.78% |
| 2018 Q1 | 2.08 Billion USD | -4.01% |
| 2018 Q2 | 1.7 Billion USD | -18.3% |
| 2018 Q4 | 1.45 Billion USD | -3.64% |
| 2017 Q1 | 1.65 Billion USD | 0.55% |
| 2017 FY | 2.16 Billion USD | 31.85% |
| 2017 Q4 | 2.16 Billion USD | -5.57% |
| 2017 Q3 | 2.29 Billion USD | 15.54% |
| 2017 Q2 | 1.98 Billion USD | 20.19% |
| 2016 FY | 1.64 Billion USD | 2.24% |
| 2016 Q1 | 1.61 Billion USD | 0.56% |
| 2016 Q2 | 1.62 Billion USD | 0.56% |
| 2016 Q3 | 1.63 Billion USD | 0.49% |
| 2016 Q4 | 1.64 Billion USD | 0.61% |
| 2015 Q1 | 912.61 Million USD | 0.8% |
| 2015 FY | 1.6 Billion USD | 77.71% |
| 2015 Q3 | 927.25 Million USD | 0.8% |
| 2015 Q2 | 919.93 Million USD | 0.8% |
| 2015 Q4 | 1.6 Billion USD | 73.52% |
| 2014 Q2 | 810.71 Million USD | 1.43% |
| 2014 Q3 | 908.8 Million USD | 12.1% |
| 2014 Q4 | 905.38 Million USD | -0.38% |
| 2014 Q1 | 799.29 Million USD | 1.84% |
| 2014 FY | 905.38 Million USD | 15.36% |
| 2013 FY | 784.86 Million USD | 198.5% |
| 2013 Q4 | 784.86 Million USD | 1.91% |
| 2013 Q3 | 770.18 Million USD | 1.14% |
| 2013 Q2 | 761.49 Million USD | 18.4% |
| 2013 Q1 | 643.17 Million USD | 144.61% |
| 2012 Q3 | 261.69 Million USD | -3.24% |
| 2012 Q2 | 270.46 Million USD | 17.97% |
| 2012 Q1 | 229.26 Million USD | -5.08% |
| 2012 FY | 262.93 Million USD | 8.87% |
| 2012 Q4 | 262.93 Million USD | 0.48% |
| 2011 FY | 241.52 Million USD | 28.02% |
| 2011 Q4 | 241.52 Million USD | 25.92% |
| 2011 Q3 | 191.8 Million USD | 0.53% |
| 2011 Q1 | 189.5 Million USD | 0.45% |
| 2011 Q2 | 190.8 Million USD | 0.68% |
| 2010 FY | 188.66 Million USD | 2.34% |
| 2010 Q1 | 185.52 Million USD | 0.63% |
| 2010 Q3 | 187.83 Million USD | -35.6% |
| 2010 Q4 | 188.66 Million USD | 0.44% |
| 2010 Q2 | 291.68 Million USD | 57.23% |
| 2009 Q1 | 182.02 Million USD | -19.94% |
| 2009 Q2 | 156.48 Million USD | -14.03% |
| 2009 FY | 184.35 Million USD | -7.82% |
| 2009 Q3 | 183.6 Million USD | 17.33% |
| 2009 Q4 | 184.35 Million USD | 0.41% |
| 2008 Q4 | 227.36 Million USD | 13.68% |
| 2008 FY | 200 Million USD | 0.0% |
| 2008 Q1 | 200 Million USD | 0.0% |
| 2008 Q2 | 228.14 Million USD | 14.07% |
| 2008 Q3 | 200 Million USD | -12.34% |
| 2007 FY | 200 Million USD | 344.44% |
| 2007 Q3 | 20 Million USD | -33.33% |
| 2007 Q4 | 200 Million USD | 900.0% |
| 2007 Q2 | 30 Million USD | 0.0% |
| 2007 Q1 | 30 Million USD | -33.33% |
| 2006 FY | 45 Million USD | 0.0% |
| 2006 Q3 | 15 Million USD | 0.0% |
| 2006 Q2 | 15 Million USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q4 | 45 Million USD | 200.0% |
| 2005 FY | - USD | -100.0% |
| 2005 Q1 | 4.95 Million USD | 161.56% |
| 2005 Q2 | 4.91 Million USD | -0.85% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q3 | 1.76 Million USD | -64.03% |
| 2004 Q2 | - USD | 0.0% |
| 2004 FY | 1.89 Million USD | 0.0% |
| 2004 Q4 | 1.89 Million USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q2 | 8.5 Million USD | 1.97% |
| 2003 FY | - USD | -100.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | -100.0% |
| 2003 Q1 | 8.33 Million USD | 0.0% |
| 2002 FY | 3.35 Million USD | -1.5% |
| 2001 FY | 3.4 Million USD | 0.0% |
| 2000 FY | - USD | -100.0% |
| 1999 FY | 17.29 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Cigna Corporation | 31.48 Billion USD | 92.424% |
| Centene Corporation | 17.82 Billion USD | 86.623% |
| CVS Health Corporation | 79.38 Billion USD | 96.996% |
| Elevance Health Inc. | 25.12 Billion USD | 90.506% |
| Humana Inc. | 12.26 Billion USD | 80.561% |
| Oscar Health, Inc. | 298.77 Million USD | -698.254% |
| UnitedHealth Group Incorporated | 67.43 Billion USD | 96.463% |